Evidence map›Paper›PMID 28272505›Full record

ArticleScientific reports2017

Enhanced cellular uptake of size-separated lipophilic silicon nanoparticles.

Aubrey E Kusi-Appiah, Melanie L Mastronardi, Chenxi Qian, Kenneth K Chen, Lida Ghazanfari, Plengchart Prommapan, Christian Kübel, Geoffrey A Ozin, Steven Lenhert

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aubrey E Kusi-AppiahDepartment of Biological Science, Florida State University, Tallahassee, Florida, USA.
Melanie L MastronardiDepartment of Chemistry, University of Toronto, Toronto, Canada.
Chenxi QianDepartment of Chemistry, University of Toronto, Toronto, Canada.
Kenneth K ChenDepartment of Chemistry, University of Toronto, Toronto, Canada.
Lida GhazanfariDepartment of Biological Science, Florida State University, Tallahassee, Florida, USA.
Plengchart PrommapanDepartment of Physics, Florida State University, Tallahassee, Florida, USA.
Christian KübelInstitute of Nanotechnology and Karlsruhe Nano Micro Facility, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Geoffrey A OzinDepartment of Chemistry, University of Toronto, Toronto, Canada.
Steven LenhertDepartment of Biological Science, Florida State University, Tallahassee, Florida, USA.

Funding

High-throughput lipophilic drug screening microarraysR01GM107172 · NIGMS · FLORIDA STATE UNIVERSITY · PI LENHERT, STEVEN · 2013 to 2017
$1.3M
NIGMS NIH HHS R01 GM107172
6 · The paper itself

Abstract

Specific size, shape and surface chemistry influence the biological activity of nanoparticles. In the case of lipophilic nanoparticles, which are widely used in consumer products, there is evidence that particle size and formulation influences skin permeability and that lipophilic particles smaller than 6 nm can embed in lipid bilayers. Since most nanoparticle synthetic procedures result in mixtures of different particles, post-synthetic purification promises to provide insights into nanostructure-function relationships. Here we used size-selective precipitation to separate lipophilic allyl-benzyl-capped silicon nanoparticles into monodisperse fractions within the range of 1 nm to 5 nm. We measured liposomal encapsulation and cellular uptake of the monodisperse particles and found them to have generally low cytotoxicities in Hela cells. However, specific fractions showed reproducibly higher cytotoxicity than other fractions as well as the unseparated ensemble. Measurements indicate that the cytotoxicity mechanism involves oxidative stress and the differential cytotoxicity is due to enhanced cellular uptake by specific fractions. The results indicate that specific particles, with enhanced suitability for incorporation into lipophilic regions of liposomes and subsequent in vitro delivery to cells, are enriched in certain fractions.

Indexed as

NanoparticlesSiliconBiological TransportCell SurvivalFluorescent Antibody TechniqueHeLa CellsHumansHydrophobic and Hydrophilic InteractionsLiposomesParticle SizeLiposomesSilicon

Identifiers

PMID28272505
PMCPMC5341124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.